MitraClip for papillary muscle rupture in patient with cardiogenic shock

Rafael Wolff1, Gideon Cohen1, Carly Peterson1

  • 1Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.

Insights

The MitraClip device successfully treated a patient with severe heart attack complications. This minimally invasive procedure addressed papillary muscle rupture and cardiogenic shock, offering a new treatment option.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • ST-elevation myocardial infarction (STEMI) can lead to severe mechanical complications.
  • Papillary muscle rupture is a rare but life-threatening complication of STEMI, often resulting in acute mitral regurgitation and cardiogenic shock.
  • Traditional management of this condition carries high mortality rates.

Observation:

  • A 68-year-old male presented with a posterolateral STEMI.
  • The patient developed cardiogenic shock attributed to papillary muscle rupture and severe mitral regurgitation.
  • The clinical scenario necessitated an urgent and effective intervention to restore hemodynamic stability.

Findings:

  • The MitraClip device was successfully deployed in the patient.
  • The procedure effectively reduced mitral regurgitation.
  • Hemodynamic improvement and resolution of cardiogenic shock were observed post-intervention.

Implications:

  • This case demonstrates the feasibility and efficacy of the MitraClip device in managing acute mechanical complications of STEMI.
  • Percutaneous mitral valve repair may offer a less invasive alternative to surgical intervention for selected patients with papillary muscle rupture.
  • Further research is warranted to establish the long-term outcomes and optimal patient selection for this approach.

Related Concept Videos